- Carlyle Group (CG +0.5%) is in advanced talks to buy Granules India, a pharmaceuticals maker, for ~$1B, India's CNBC-TV18 reports, citing three sources with direct knowledge of the deal.
- That would add on to Carlyle's pharmaceutical industry investments after recently acquiring Sequent Scientific and a minority stake in Piramal Pharma.
- Carlyle is expected to initially buy promoter shares, which would trigger an open offer to buy additional shares from others.
- Both Granules India and Carlyle didn't comment on the deal when contacted by CNBC-TV18.
- https://seekingalpha.com/news/3639695-carlyle-group-nears-acquisition-of-india-pharma-firm-for-1b-cnbc-tv18
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.